Abstract
In Australia, in recent years, there have been a number of news reports of patients
Hope is something that we hold dear and we encourage patients to have hope that there will be a breakthrough or there will be cure…. And to have hopes dashed can be very difficult for families, friends to, to cope with.
(Michael, representative from Australian patient advocacy group, interviewed in 2012)
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Australian Rheumatology Association. (2015). ARA position statement on stem cell therapies. https://rheumatology.org.au/downloads/ARA%20Position%20Statement%20042014.pdf. Accessed 26 Feb 2016.
Australian Stem Cell Centre. (2009). Stem cell therapies, now and in the future: The Australian Stem Cell Centre patient handbook. Melbourne: ASCC.
Braude, P., Minger, S. L., & Warwick, R. M. (2005). Stem cell therapy: Hope or hype? Safety and quality must be assured before this treatment can really benefit patients. British Medical Journal, 330(7501), 1159–1160.
Brown, N. (2003). Hope against hype: Accountability in biopasts, presents and futures. Science Studies, 16(2), 3–21.
Brown, N. (2015). Metrics of hope: Disciplining affect in oncology. Health: An Interdisciplinary Journal for the Social Study of Health Illness and Medicine, 19(2), 119–136.
Daley, G. (2012). The promise and perils of stem cell therapeutics. Cell Stem Cell, 10(6), 740–749.
Daley, G. Q., Goodell, M. A., Snyder E. Y. (2003). Realistic prospects for stem cell therapeutics. Hematology American Society of Hematology Education Program, 398–418.
Hyun, I. (2013). Therapeutic hope, spiritual distress, and the problem of stem cell tourism. Cell Stem Cell, 12, 505–507.
Hyun, I., Lindvall, O., Ahrlund-Richter, L., Cattaneo, E., et al. (2008). New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell, 3, 607–609.
Ipsos Social Research. (2013). Community attitudes towards emerging technology issues – biotechnology. http://www.industry.gov.au/industry/IndustrySectors/nanotechnology/Publications/Pages/Public-Attitude-Research.aspx. Accessed 26 Feb 2016.
Levine, A. D., & Wolf, L. E. (2012). The roles and responsibilities of physicians in patients’ decisions about unproven stem cell therapies. Journal of Law & Medical Ethics, 40, 122–134.
Lysaght, T., & Kerridge, I. (2012). Rhetoric, power and legitimacy: A critical analysis of public policy disputes surrounding stem cell research in Australia (2005–2006). Public Understanding of Science, 21(2), 195–210.
Master, Z., Zarzecny, A., Rachul, C., & Caulfield, T. (2013). What’s missing? Discussing stem cell translational research in educational information on stem cell “tourism”. Journal of Law, Medicine and Ethics, 41(1), 254–268.
Master, Z., Robertson, K., Frederick, D., Rachul, C., et al. (2014). Stem cell tourism and public education: The missing elements. Cell Stem Cell, 15, 267–270.
McLean, A., Stewart, C., & Kerridge, I. (2014). The emergence and popularisation of autologous somatic cellular therapies in Australia: Therapeutic innovation or regulatory failure? Journal of Law and Medicine, 22(1), 65–89.
Moreira, T., & Palladino, P. (2005). Between truth and hope: On Parkinson’s disease, neurotransplantation and the production of the ‘self’. History of the Human Sciences, 18(3), 55–82.
Munsie, M., & Pera, M. (2014). Regulatory loophole enables unproven autologous cell therapies to thrive in Australia. Stem Cells and Development, 23(S1), 34–38.
Murdoch, C., & Scott, C. (2010). Stem cell tourism and the power of hope. The American Journal of Bioethics, 10(5), 16–23.
National Health and Medical Research Council. (2013). Stem cell treatments—A quick guide for medical practitioners and stem cell treatments—Frequently asked questions. https://www.nhmrc.gov.au/guidelines-publications/rm001. Accessed 26 Feb 2016.
Nature Editorial. (2010). Regulators must step up stem cell oversight. Nature Medicine, 16, 492.
Nelson, B. (2008, June 5). Stem cell researchers face down stem cell tourism. Nature Reports Stem Cells. http://www.nature.com/stemcells/2008/0806/080605/full/stemcells.2008.89.html. Accessed 9 Mar 2016.
Osbourne, H., Anderson, L., Burt, P., Young, M., et al. (2016). Australasian College of Sports Physicians—Position statement: The place of mesenchymal stem/stromal cell therapies in sport and exercise medicine. British Journal of Sports Medicine, 50, 1237–1244.
Petersen, A., Seear, K., & Munsie, M. (2014). Therapeutic journeys: The hopeful travails of stem cell tourists. Sociology of Health and Illness, 36(5), 670–685.
Petersen, A., Tanner, C., & Munsie, M. (2015). Between hope and evidence: How community advisors demarcate the boundary between legitimate and illegitimate stem cell treatments. Health, 19(2), 188–206.
Taylor, P. L., Barker, R. A., Blume, K. G., Cattaneo, E., et al. (2010). Patients beware: Commercialized stem cell treatments on the web. Cell Stem Cell, 7(1), 43–49.
Trounson, A., & Harvey, R. P. (2008). A critical time for stem cell research in Australia. Cell Stem Cell, 2(2), 118–122.
Zarzeczny, A., & Caulfield, T. (2010). Stem cell tourism and doctor’s duties to minors—A view from Canada. American Journal of Bioethics, 10, 3–15.
Author information
Authors and Affiliations
Copyright information
© 2017 The Author(s)
About this chapter
Cite this chapter
Petersen, A., Munsie, M., Tanner, C., MacGregor, C., Brophy, J. (2017). Managing Hope. In: Stem Cell Tourism and the Political Economy of Hope. Health, Technology and Society. Palgrave Macmillan, London. https://doi.org/10.1057/978-1-137-47043-0_3
Download citation
DOI: https://doi.org/10.1057/978-1-137-47043-0_3
Published:
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-137-47042-3
Online ISBN: 978-1-137-47043-0
eBook Packages: Social SciencesSocial Sciences (R0)